XRF Scientific (ASX:XRF) has released its unaudited March quarterly trading results, highlighting a solid performance across all divisions.
Despite a quieter January following a record-breaking December 2024, the company saw a rebound in February and March, which together contributed 76% of the quarter's profit.
Key growth drivers included the mining industry and expanding international sales, particularly in Asia, the Americas, Europe, and parts of Africa.
Total revenue for the March quarter was $13.9 million, down 9% from $15.2 million in the prior corresponding period, while profit before tax rose 5% to $3.4 million, up from $3.2 million.
Year-to-date revenue for the nine months to March 31 was $42.4 million, representing a 3% dip from the year-ago period, but profit before tax climbed 10% to $10.3 million.
Consumables continued to perform well, with sales of $4.4 million, nearly in line with the $4.5 million reported a year earlier.
The mining sector remained the primary source of demand, supported by lower production costs and pricing due to a drop in lithium raw material prices.
Capital Equipment sales reached $4.5 million, slightly below the $5 million in the prior-year period.
Order intake remained steady, although some machine invoicing was deferred to the June quarter.
The company saw progress in international markets, particularly in South America, where Orbis laboratory crushers gained traction through a new distributor.
At the time of reporting, XRF Scientific's share price was $1.74.